Stocktoria

Exousia Bio, Inc. LMMY

OTC · stock · Services-Educational Services · website · IPO 2024-04-30

Exousia Bio, Inc. (LMMY) earns a Piotroski F-score of 1/9 (weak financial health). It does not currently pay a dividend.

$0.68 high · $0.02 low · monthly closes · hover for date & price
11/100
Stocktoria Quality Score · grade D
1/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend yield · no dividend

Quality score trend · recomputed for each fiscal year

Piotroski F /9
4 2 1 0 1 20242025202520252026

Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.

$0.02 as of 2026-09-01 · -90.6% 1y
$0.02$0.6852-wk
Market cap USD$32M
Net margin 5y avg573%
Revenue trend · last 3y · up

How it ranks in Services · percentile among 1013 companies

Piotroski Fstronger than 1%

Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 1/9 tests passed

Sector peers · similar-size Services companies compare side by side →

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
LMMYExousia Bio, Inc.1/9———
EDUNew Oriental Education & Technology Group Inc.6/93.7115.5+15.5%
GHCGraham Holdings Co6/95.6617.1+2.5%
TALTAL Education Group7/94.379.3+33.7%
LRNStride, Inc.7/97.9711+4.7%
STGSunlands Technology Group8/90.28—+1.5%
CVSACovista Inc.7/95.0517.3+9.3%

All Services companies →

About Exousia Bio, Inc.

LAMY designs, develops, and operates an eLearning and gaming marketplace platform. It offers TwoPlus1, an educational video game that provides financial knowledge and resource management to children. The company was incorporated in 2022 and is based in New York, New York.

FAQ

Is LMMY financially healthy?

Exousia Bio, Inc.'s Piotroski F-score is 1/9 (8–9 is excellent, 0–3 weak).

Does LMMY pay a dividend?

No, Exousia Bio, Inc. does not currently pay a dividend.

Is LMMY a good stock to buy?

Stocktoria doesn't give buy or sell advice, but here is the data on Exousia Bio, Inc.: a Piotroski F-score of 1/9. Weigh these quality and valuation signals against your own goals.

Computed from company filings · US · as of 2026-02-28. Facts plus Stocktoria's own computed scores — not investment advice.